Want to see CLYM full AI Analyst Report?
Climb Bio (CLYM) Ownership Overview
20.16% Insiders
5.55% Mutual Funds
39.82% Other Institutional Investors
6.59% ETFs
27.87% Public Companies and
Individual Investors
The ownership structure of Climb Bio (CLYM) stock is a mix of institutional, retail, and individual investors. Approximately 51.97% of the company’s stock is owned by Institutional Investors, 20.16% is owned by Insiders, and 27.87% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jan 07, 2026 | xxxxxxxxxxxxx | $24889 | |
Dec 15, 2025 | xxxxxxxxxxxxx | $754737 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $77411432 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,300,939 | Institution | 19.74% | 149,285,404 | |
| 11,300,939 | Insider | 19.74% | 149,285,404 | |
| 1,468,417 | Institution | 2.56% | 19,397,789 | |
| 1,387,693 | Institution | 2.42% | 18,331,425 | |
| 1,379,862 | Institution | 2.41% | 18,227,977 | |
| 1,147,895 | Institution | 2.00% | 15,163,693 | |
| 600,946 | Institution | 1.05% | 7,938,497 | |
| 392,706 | Institution | 0.69% | 5,187,646 | |
| 258,563 | Institution | 0.45% | 3,415,617 | |
| 154,657 | Insider | 0.27% | 2,043,019 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,468,417 | Institution | 2.56% | 19,397,789 | |
| 1,147,895 | Institution | 2.00% | 15,163,693 | |
| 258,563 | Institution | 0.45% | 3,415,617 | |
| 123,800 | Institution | 0.22% | 1,635,398 | |
| 50,450 | Institution | 0.09% | 666,445 | |
| 39,953 | Institution | 0.07% | 527,779 | |
| 32,453 | Institution | 0.06% | 428,704 | |
| 22,000 | Institution | 0.04% | 290,620 | |
| 16,894 | Institution | 0.03% | 223,170 | |
| 13,870 | Institution | 0.02% | 183,223 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 985,986 | Institution | 1.72% | 10,806,407 | |
| 932,850 | Institution | 1.63% | 13,059,900 | |
| 389,134 | Institution | 0.68% | 5,447,876 | |
| 292,417 | Institution | 0.51% | 3,204,890 | |
| 182,868 | Institution | 0.32% | 2,415,686 | |
| 145,788 | Institution | 0.25% | 2,041,032 | |
| 118,497 | Institution | 0.21% | 1,658,958 | |
| 109,290 | Institution | 0.19% | 1,530,060 | |
| 76,929 | Institution | 0.13% | 1,077,006 | |
| 76,109 | Institution | 0.13% | 1,065,526 |
FAQ
Who Owns Climb Bio, Inc. (CLYM)?
According to the latest TipRanks data, approximately 39.82% of the company's stock is held by institutional investors, 20.16% is held by insiders, and 27.87% is held by retail investors.
What percentage of Climb Bio, Inc. (CLYM) stock is held by institutional investors?
According to the latest TipRanks data, approximately 39.82% of Climb Bio, Inc. (CLYM) stock is held by institutional investors.
What percentage of Climb Bio, Inc. (CLYM) stock is held by retail investors?
According to the latest TipRanks data, approximately 27.87% of Climb Bio, Inc. (CLYM) stock is held by retail investors.
Who owns the most shares of Climb Bio, Inc. (CLYM)?
Peter Kolchinsky owns the most shares of Climb Bio, Inc. (CLYM).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.